{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T03:27:56Z","timestamp":1786332476329,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":69,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16277-8","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:26:11Z","timestamp":1780410371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor immune microenvironment and epithelial\u2013mesenchymal transition in recurrence of low-grade stage IA endometrial endometrioid carcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Kazuhisa","family":"Hachisuga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Inomata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Maenohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Onoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Asanoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Yahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinao","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"1","key":"16277_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","volume":"15","author":"JV Bokhman","year":"1983","unstructured":"Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983;15(1):10\u20137.","journal-title":"Gynecol Oncol"},{"issue":"7447","key":"16277_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"C Kandoth","year":"2013","unstructured":"Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67\u201373.","journal-title":"Nature"},{"key":"16277_CR3","unstructured":"WHO Classification of Tumours Editorial Board. Female Genital Tumours, WHO Classification of Tumours. 5th ed. In., edn. 2020."},{"issue":"5","key":"16277_CR4","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359\u201386.","journal-title":"Int J Cancer"},{"issue":"1","key":"16277_CR5","doi-asserted-by":"publisher","first-page":"12758","DOI":"10.1038\/s41598-024-63305-3","volume":"14","author":"W Li","year":"2024","unstructured":"Li W, Zhang X, Yang Y, Lin J, Zhou K, Sun R, Dang C, Diao D. Circulating tumor cells are a good predictor of tumor recurrence in clinical patients with gastric cancer. Sci Rep. 2024;14(1):12758.","journal-title":"Sci Rep"},{"key":"16277_CR6","doi-asserted-by":"crossref","unstructured":"Wei C, Yang CG, Wang SY, Shi DD, Zhang CX, Lin XB, Liu Q, Dou RZ, Xiong B. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis. Mol Cancer. 2019;18(1):64.","DOI":"10.1186\/s12943-019-0976-4"},{"key":"16277_CR7","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1186\/s12885-016-2526-4","volume":"16","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Wang B, Wu J, Zhang C, Zhou Y, Yang X, Zhou J, Guo W, Fan J. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection. BMC Cancer. 2016;16:506.","journal-title":"BMC Cancer"},{"issue":"3","key":"16277_CR8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"16277_CR9","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1038\/s41591-024-03254-6","volume":"30","author":"Y Nakamura","year":"2024","unstructured":"Nakamura Y, Watanabe J, Akazawa N, Hirata K, Kataoka K, Yokota M, Kato K, Kotaka M, Kagawa Y, Yeh KH, et al. ctDNA-based molecular residual disease and survival in resectable colorectal cancer. Nat Med. 2024;30(11):3272\u201383.","journal-title":"Nat Med"},{"issue":"9","key":"16277_CR10","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1001\/jamaoncol.2020.2295","volume":"6","author":"M Radovich","year":"2020","unstructured":"Radovich M, Jiang G, Hancock BA, Chitambar C, Nanda R, Falkson C, Lynce FC, Gallagher C, Isaacs C, Blaya M, et al. Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial. JAMA Oncol. 2020;6(9):1410\u20135.","journal-title":"JAMA Oncol"},{"key":"16277_CR11","doi-asserted-by":"crossref","unstructured":"Goldkorn A, Tangen C, Plets M, Bsteh D, Xu T, Pinski JK, Ingles S, Triche TJ, Macvicar GR, Vaena DA et al. Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer. Jama Netw Open. 2024;7(10):e2437871.","DOI":"10.1001\/jamanetworkopen.2024.37871"},{"key":"16277_CR12","unstructured":"Skin tumours. UICC TNM Classification of Malignant Tumours. 8th ed. In., edn. 2016."},{"issue":"11","key":"16277_CR13","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s10147-019-01484-0","volume":"24","author":"S Vagios","year":"2019","unstructured":"Vagios S, Yiannou P, Giannikaki E, Doulgeraki T, Papadimitriou C, Rodolakis A, Nonni A, Vlachos A, Pavlakis K. The impact of programmed cell death-ligand 1 (PD-L1) and CD8 expression in grade 3 endometrial carcinomas. Int J Clin Oncol. 2019;24(11):1419\u201328.","journal-title":"Int J Clin Oncol"},{"issue":"9","key":"16277_CR14","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1097\/IGC.0b013e31822c271f","volume":"21","author":"W Yamagami","year":"2011","unstructured":"Yamagami W, Susumu N, Tanaka H, Hirasawa A, Banno K, Suzuki N, Tsuda H, Tsukazaki K, Aoki D. Immunofluorescence-detected infiltration of CD4\u2009+\u2009FOXP3+ regulatory T cells is relevant to the prognosis of patients with endometrial cancer. Int J Gynecol Cancer. 2011;21(9):1628\u201334.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"16277_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ygyno.2007.12.033","volume":"109","author":"S Soeda","year":"2008","unstructured":"Soeda S, Nakamura N, Ozeki T, Nishiyama H, Hojo H, Yamada H, Abe M, Sato A. Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma. Gynecol Oncol. 2008;109(1):122\u20138.","journal-title":"Gynecol Oncol"},{"key":"16277_CR16","doi-asserted-by":"crossref","unstructured":"Kawamura T, Tomari H, Onoyama I, Araki H, Yasunaga M, Lin C, Kawamura K, Yokota N, Yoshida S, Yagi H et al. Identification of genes associated with endometrial cell ageing. Mol Hum Reprod. 2021;27(2):gaaa078.","DOI":"10.1093\/molehr\/gaaa078"},{"issue":"7","key":"16277_CR17","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671\u20135.","journal-title":"Nat Methods"},{"issue":"5","key":"16277_CR18","doi-asserted-by":"publisher","first-page":"e96801","DOI":"10.1371\/journal.pone.0096801","volume":"9","author":"F Varghese","year":"2014","unstructured":"Varghese F, Bukhari AB, Malhotra R, De A. IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS ONE. 2014;9(5):e96801.","journal-title":"PLoS ONE"},{"issue":"1","key":"16277_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1756-9966-29-71","volume":"29","author":"JF Liang","year":"2010","unstructured":"Liang JF, Wang HK, Xiao H, Li N, Cheng CX, Zhao YZ, Ma YB, Gao JZ, Bai RB, Zheng HX. Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer. J Exp Clin Cancer Res. 2010;29(1):71.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"16277_CR20","doi-asserted-by":"publisher","first-page":"2161167","DOI":"10.1080\/2162402X.2022.2161167","volume":"12","author":"F Wang","year":"2023","unstructured":"Wang F, Lu S, Cao D, Qian J, Li C, Zhang R, Wang F, Wu M, Liu Y, Pan Z, et al. Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer. Oncoimmunology. 2023;12(1):2161167.","journal-title":"Oncoimmunology"},{"issue":"5","key":"16277_CR21","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1245\/s10434-016-5714-1","volume":"24","author":"H Takeyama","year":"2017","unstructured":"Takeyama H, Shimada T, Kinoshita S, Uchida K. Usefulness of CTC and DTC-BM Detection for Adjuvant Therapy Effects and Prognosis Prediction in Early Breast Carcinoma: Results of 8\u201311 Years of Follow-up Evaluation. Ann Surg Oncol. 2017;24(5):1227\u201333.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"16277_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0090-8258(03)00126-4","volume":"89","author":"CL Creutzberg","year":"2003","unstructured":"Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, W\u00e1rl\u00e1m-Rodenhuis CC, De Winter KA, Lutgens LC, van den Bergh AC, van der Steen-Banasik E, et al. Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecol Oncol. 2003;89(2):201\u20139.","journal-title":"Gynecol Oncol"},{"key":"16277_CR23","doi-asserted-by":"crossref","unstructured":"Talaat IM, Elemam NM, Abdullah HW. CD68, CD86 and CD163 Expression Profile in Breast Cancer Molecular Subtypes. Faseb J. 2022;36(S1):R3106.","DOI":"10.1096\/fasebj.2022.36.S1.R3106"},{"issue":"11","key":"16277_CR24","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","volume":"23","author":"A Mantovani","year":"2002","unstructured":"Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002;23(11):549\u201355.","journal-title":"Trends Immunol"},{"issue":"7","key":"16277_CR25","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1111\/jog.15953","volume":"50","author":"T Matsukawa","year":"2024","unstructured":"Matsukawa T, Yoshikawa N, Liu WT, Hattori S, Yoshida K, Yoshihara M, Tamauchi S, Yokoi A, Niimi K, Kajiyama H. Spatial distribution of tumor-resident macrophages as predictive biomarkers in endometrial cancer. J Obstet Gynaecol Re. 2024;50(7):1141\u20137.","journal-title":"J Obstet Gynaecol Re"},{"issue":"5","key":"16277_CR26","first-page":"4465","volume":"15","author":"K Minami","year":"2018","unstructured":"Minami K, Hiwatashi K, Ueno S, Sakoda M, Iino S, Okumura H, Hashiguchi M, Kawasaki Y, Kurahara H, Mataki Y, et al. Prognostic significance of CD68, CD163 and Folate receptor-beta positive macrophages in hepatocellular carcinoma. Exp Ther Med. 2018;15(5):4465\u201376.","journal-title":"Exp Ther Med"},{"key":"16277_CR27","doi-asserted-by":"crossref","unstructured":"Jaaskelainen MM, Tumelius R, Hamalainen K, Rilla K, Oikari S, Ronka A, Selander T, Mannermaa A, Tiainen S, Auvinen P. High Numbers of CD163\u2009+\u2009Tumor-Associated Macrophages Predict Poor Prognosis in HER2\u2009+\u2009Breast Cancer. Cancers (Basel). 2024;16(3):634.","DOI":"10.3390\/cancers16030634"},{"issue":"2","key":"16277_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ygyno.2014.08.028","volume":"135","author":"K Kubler","year":"2014","unstructured":"Kubler K, Ayub TH, Weber SK, Zivanovic O, Abramian A, Keyver-Paik MD, Mallmann MR, Kaiser C, Serce NB, Kuhn W, et al. Prognostic significance of tumor-associated macrophages in endometrial adenocarcinoma. Gynecol Oncol. 2014;135(2):176\u201383.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"16277_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.molonc.2012.07.002","volume":"7","author":"HO Smith","year":"2013","unstructured":"Smith HO, Stephens ND, Qualls CR, Fligelman T, Wang T, Lin CY, Burton E, Griffith JK, Pollard JW. The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma. Mol Oncol. 2013;7(1):41\u201354.","journal-title":"Mol Oncol"},{"issue":"10","key":"16277_CR30","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/glia.20679","volume":"56","author":"WA Golembieski","year":"2008","unstructured":"Golembieski WA, Thomas SL, Schultz CR, Yunker CK, McClung HM, Lemke N, Cazacu S, Barker T, Sage EH, Brodie C, et al. HSP27 mediates SPARC-induced changes in glioma morphology, migration, and invasion. Glia. 2008;56(10):1061\u201375.","journal-title":"Glia"},{"issue":"4","key":"16277_CR31","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/neuonc\/nos326","volume":"15","author":"R Alam","year":"2013","unstructured":"Alam R, Schultz CR, Golembieski WA, Poisson LM, Rempel SA. PTEN suppresses SPARC-induced pMAPKAPK2 and inhibits SPARC-induced Ser78 HSP27 phosphorylation in glioma. Neuro Oncol. 2013;15(4):451\u201361.","journal-title":"Neuro Oncol"},{"issue":"6","key":"16277_CR32","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s13402-022-00708-2","volume":"45","author":"T Kolben","year":"2022","unstructured":"Kolben T, Mannewitz M, Perleberg C, Schnell K, Anz D, Hahn L, Meister S, Schmoeckel E, Burges A, Czogalla B, et al. Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells. Cell Oncol. 2022;45(6):1171\u201385.","journal-title":"Cell Oncol"},{"issue":"1","key":"16277_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cellimm.2012.09.009","volume":"279","author":"JF Heiber","year":"2012","unstructured":"Heiber JF, Geiger TL. Context and location dependence of adaptive Foxp3(+) regulatory T cell formation during immunopathological conditions. Cell Immunol. 2012;279(1):60\u20135.","journal-title":"Cell Immunol"},{"key":"16277_CR34","doi-asserted-by":"crossref","unstructured":"Egelston CA, Guo W, Tan J, Avalos C, Simons DL, Lim MH, Huang YJ, Nelson MS, Chowdhury A, Schmolze DB et al. Tumor-infiltrating exhausted CD8\u2009+\u2009T cells dictate reduced survival in premenopausal estrogen receptor-positive breast cancer. JCI Insight. 2022;7(3):e153963.","DOI":"10.1172\/jci.insight.153963"},{"issue":"2","key":"16277_CR35","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.3802\/jgo.2021.32.e22","volume":"32","author":"C Nwachukwu","year":"2021","unstructured":"Nwachukwu C, Baskovic M, Von Eyben R, Fujimoto D, Giaretta S, English D, Kidd E. Recurrence risk factors in stage IA grade 1 endometrial cancer. J Gynecol Oncol. 2021;32(2):e22.","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"16277_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","volume":"31","author":"N Concin","year":"2021","unstructured":"Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, Ledermann J, Bosse T, Chargari C, Fagotti A, et al. ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2021;31(1):12\u201339.","journal-title":"Int J Gynecol Cancer"},{"issue":"13","key":"16277_CR37","doi-asserted-by":"publisher","first-page":"8495","DOI":"10.1245\/s10434-023-14168-x","volume":"30","author":"J Yu","year":"2023","unstructured":"Yu J, Bai Y, Jin L, Zhang Z, Yang Y. A Prospective Long-Term Follow-Up Study: The Application of Circulating Tumor Cells Analysis to Guide Adjuvant Therapy in Stage II Colorectal Cancer. Ann Surg Oncol. 2023;30(13):8495\u2013500.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"16277_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.canlet.2015.06.020","volume":"367","author":"R Maltoni","year":"2015","unstructured":"Maltoni R, Fici P, Amadori D, Gallerani G, Cocchi C, Zoli M, Rocca A, Cecconetto L, Folli S, Scarpi E, et al. Circulating tumor cells in early breast cancer: A connection with vascular invasion. Cancer Lett. 2015;367(1):43\u20138.","journal-title":"Cancer Lett"},{"key":"16277_CR39","doi-asserted-by":"publisher","first-page":"9655","DOI":"10.2147\/CMAR.S270881","volume":"12","author":"Q Gao","year":"2020","unstructured":"Gao Q, Guo L, Wang B. The Pathogenesis and Prevention of Port-Site Metastasis in Gynecologic Oncology. Cancer Manag Res. 2020;12:9655\u201363.","journal-title":"Cancer Manag Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16277-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16277-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16277-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T02:31:28Z","timestamp":1786329088000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16277-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16277"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16277-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. This retrospective study using archived clinical data and tissue samples was approved by the institutional review board of Kyushu University (project number: 24101-00). The need for informed consent was waived, and an opt-out approach was used in accordance with institutional regulations.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"953"}}